Mode
Text Size
Log in / Sign up

Autonomic gastrointestinal dysfunction occurs in 31.4% of people with multiple sclerosisMany people with multiple sclerosis experience significant digestive issues

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize that autonomic gastrointestinal dysfunction is common in multiple sclerosis, affecting approximately 31.4% of patients.

This meta-analysis evaluates the prevalence of gastrointestinal (GI) symptoms and disorders among 1,272,170 people with multiple sclerosis (pwMS). The analysis synthesizes data on autonomic GI dysfunction, dysphagia, bowel dysfunction, and specific upper and lower GI manifestations to characterize the scope of GI involvement in this population.

The meta-analysis found a prevalence of 31.4% for autonomic GI dysfunction (95% CI 26.4-36.5%) and 43.4% for dysphagia (95% CI 35.9-51.0%). Bowel dysfunction was reported in 37.9% of patients (95% CI 25.0-51.8%). Additionally, the odds of autonomic GI dysfunction were significantly higher in pwMS compared to controls (OR 3.26; 95% CI 1.81-5.86). Lower GI symptoms were more prevalent than upper GI manifestations (28.9% vs 11.5%).

The authors note substantial between-study heterogeneity due to variations in assessment methods and study populations, which means pooled estimates serve as general indicators rather than precise predictors. Clinically, these findings underscore that autonomic GI involvement is a common aspect of MS, highlighting the need for standardized outcome definitions and structured clinical screening programs.

How this fits prior evidence

This meta-analysis addresses a gap in characterizing the prevalence of gastrointestinal symptoms in multiple sclerosis. While prior coverage has established the efficacy of fingolimod in reducing relapses and the diagnostic limitations of serum neurofilament light chain, this study specifically quantifies the high prevalence of autonomic GI dysfunction (OR 3.26) and dysphagia (43.4%) in the MS population.

Living with multiple sclerosis often involves more than just mobility challenges. Many people with this condition also struggle with their digestive systems. A large review of data from over 1.2 million people shows that gastrointestinal issues are very common among those living with MS.

Specifically, the study found that about 31.4% of people with MS experience autonomic gut dysfunction, which is a condition where the nervous system affects digestion. Other common issues include difficulty swallowing (found in 43.4% of cases) and bowel problems (affecting 37.9%). Lower digestive tract symptoms were much more common than upper ones.

Because these issues are so common, experts suggest that doctors should use more consistent ways to check for and track these symptoms. While the data shows a clear link between MS and gut problems, the study noted that different testing methods made it hard to compare every result perfectly.

What this means for you:
Digestive issues like swallowing difficulties and bowel dysfunction are common in people with multiple sclerosis.

Common questions

How common are digestive problems in people with MS?

Digestive issues are very common. The study found that 31.4% of people with multiple sclerosis experience autonomic gut dysfunction. Additionally, about 43.4% of those with the condition reported difficulty swallowing, and 37.9% experienced bowel dysfunction.

What specific types of digestive issues were found?

The research identified several types of problems. Lower gastrointestinal symptoms were more common than upper ones, with a rate of 28.9% compared to 11.5%. These findings highlight that many different parts of the digestive system can be affected by multiple sclerosis.

Is there a link between MS and gut issues?

Yes, the data shows a clear link. People with multiple sclerosis were found to have much higher odds of autonomic gut dysfunction compared to those without the condition. Because these symptoms are common, doctors may need to use more standard ways to screen for them.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Gastrointestinal (GI) symptoms and disorders are frequently reported in multiple sclerosis (MS), but the evidence remains fragmented and highly diverse. We conducted a systematic review and meta-analysis to define the extent and range of GI symptoms and disorders in people with MS (pwMS). METHODS: PubMed, Scopus, and Web of Science were searched from inception through October 1, 2025. Eligible studies included observational and interventional designs that reported GI symptoms or diseases in MS. Random-effects meta-analyses were performed for outcomes reported by three or more studies. Prevalence estimates were pooled across all eligible studies, and odds ratios (ORs) were additionally calculated for outcomes reported in case-control studies. RESULTS: A total of 114 studies involving 1,272,170 pwMS were included. Autonomic GI dysfunction was the predominant phenotype, affecting approximately one-third of pwMS (31.4% [95% CI 26.4-36.5%]), with a high prevalence of dysphagia (43.4% [95% CI 35.9-51.0%]) and bowel dysfunction (37.9% [95% CI 25.0-51.8%]). When analyzed by anatomical domains, lower GI symptoms and disorders were more frequent than upper GI manifestations (28.9% vs 11.5%). In case-control analyses, pwMS had significantly higher odds of autonomic GI dysfunction compared with controls (OR 3.26 [95% CI 1.81-5.86]). Substantial between-study heterogeneity was present across all analyses. CONCLUSIONS: Autonomic GI involvement is a common and clinically important aspect of MS. Marked heterogeneity reflects differences in assessment methods and populations, supporting the view of pooled estimates as general indicators and emphasizing the need for standardized outcome definitions and structured clinical screening.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.